Skip to main content
Clinical Trials/NCT05455125
NCT05455125
Unknown
Not Applicable

A Cardiac Sub-Study of the MRC National Survey of Health and Development (NSHD)

University College, London1 site in 1 country550 target enrollmentJuly 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Frailty
Sponsor
University College, London
Enrollment
550
Locations
1
Primary Endpoint
CMR phenotype - Aortic blood flow
Last Updated
3 years ago

Overview

Brief Summary

Background The life course accumulation of overt and subclinical myocardial dysfunction contributes to older age mortality, frailty, disability and loss of independence. The Medical Research Council National Survey of Health and Development (NSHD) is the world's longest running continued surveillance birth cohort providing a unique opportunity to understand life course determinants of myocardial dysfunction as part of MyoFit46-the cardiac sub-study of the NSHD.

Methods and expected results The investigators aim to recruit 550 NSHD participants of approximately 75 years+ to undertake high-density surface electrocardiographic imaging (ECGI) and stress perfusion cardiovascular magnetic resonance (CMR). Through comprehensive myocardial tissue characterization and 4-dimensional flow the investigators hope to better understand the burden of clinical and subclinical cardiovascular disease. Supercomputers will be used to combine the multi-scale ECGI and CMR datasets per participant. Rarely available, prospectively collected whole-of-life data on exposures, traditional risk factors and multimorbidity will be studied to identify risk trajectories, critical change periods, mediators and cumulative impacts on the myocardium.

Conclusion By combining well curated, prospectively acquired longitudinal data of the NSHD with novel CMR-ECGI data and sharing these results and associated pipelines with the CMR community, MyoFit46 seeks to transform our understanding of how early, mid and later-life risk factor trajectories interact to determine the state of cardiovascular health in older age.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
June 30, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • NSHD study member.
  • Who is still alive and agreed to take part in the study.

Exclusion Criteria

  • Pacemaker.
  • Implantable cardio defibrillator.
  • Atrial fibrillation.
  • Complete heart block.
  • Severe asthma.

Outcomes

Primary Outcomes

CMR phenotype - Aortic blood flow

Time Frame: Through study completion, an average of 4 years.

This will be assessed through a 45 minute cardiac MRI scan with perfusion.

CMR phenotype - Myocardial blood flow

Time Frame: Through study completion, an average of 4 years.

This will be assessed through a 45 minute cardiac MRI scan with perfusion.

CMR phenotype - T1

Time Frame: Through study completion, an average of 4 years.

This will be assessed through a 45 minute cardiac MRI scan with perfusion.

CMR phenotype - T2

Time Frame: Through study completion, an average of 4 years.

This will be assessed through a 45 minute cardiac MRI scan with perfusion.

Study Sites (1)

Loading locations...

Similar Trials